Covered recipient · General Payments record
FERDINAND LYNDON Q MAGNO
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$1,161.57
- Reported across 76 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $352.39 | 36 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $175.18 | 26 |
| DEXCOM, INC. | $51.79 | 3 |
| Inspire Medical Systems, Inc. | $22.87 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $19.76 | 1 |
| Novo Nordisk AS | $19.58 | 1 |
| Nevro Corp. | $17.07 | 1 |
| Exact Sciences Corporation | $16.22 | 1 |
| Xeris Pharmaceuticals, Inc. | $15.17 | 1 |
| Amgen Inc. | $14.75 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (36)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $14.75 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117316648 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $19.76 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118202199 | CMS |
| Dexcom, Inc. | $21.02 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153300188 | CMS |
| Dexcom, Inc. | $14.71 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153300190 | CMS |
| Dexcom, Inc. | $16.06 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153300192 | CMS |
| Exact Sciences Corporation | $16.22 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114767925 | CMS |
| Inspire Medical Systems, Inc. | $22.87 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148076388 | CMS |
| Lilly USA, LLC | $4.09 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134965563 | CMS |
| Lilly USA, LLC | $1.81 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134972955 | CMS |
| Lilly USA, LLC | $6.31 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134992912 | CMS |
| Lilly USA, LLC | $0.93 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134965565 | CMS |
| Lilly USA, LLC | $3.03 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134965567 | CMS |
| Lilly USA, LLC | $11.91 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134967131 | CMS |
| Lilly USA, LLC | $3.19 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134972377 | CMS |
| Lilly USA, LLC | $11.85 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134967133 | CMS |
| Lilly USA, LLC | $48.96 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134976220 | CMS |
| Lilly USA, LLC | $6.19 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134964021 | CMS |
| Lilly USA, LLC | $4.65 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134976222 | CMS |
| Lilly USA, LLC | $1.67 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134976224 | CMS |
| Lilly USA, LLC | $4.57 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134976226 | CMS |
| Lilly USA, LLC | $6.15 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134992914 | CMS |
| Lilly USA, LLC | $6.19 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134972957 | CMS |
| Lilly USA, LLC | $5.37 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134992916 | CMS |
| Lilly USA, LLC | $1.51 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134965569 | CMS |
| Lilly USA, LLC | $3.81 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134976028 | CMS |
| Lilly USA, LLC | $10.30 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134988914 | CMS |
| Lilly USA, LLC | $3.22 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134965571 | CMS |
| Lilly USA, LLC | $5.41 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134967137 | CMS |
| Lilly USA, LLC | $7.05 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134976030 | CMS |
| Lilly USA, LLC | $6.28 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134967135 | CMS |
| Lilly USA, LLC | $5.68 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134965573 | CMS |
| Lilly USA, LLC | $0.29 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134972959 | CMS |
| Lilly USA, LLC | $4.76 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134988916 | CMS |
| Nevro Corp. | $17.07 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130758374 | CMS |
| Novo Nordisk Inc | $19.58 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097173165 | CMS |
| Xeris Pharmaceuticals, Inc. | $15.17 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144594568 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.